Powered by
GRAND RAPIDS–Corium Pharma Solutions Inc., a contract development and manufacturing organization, today announced its new name, Corium Innovations Inc. Company officials said the name change reflects the company’s ongoing focus on offering …
ANN ARBOR–CareEvolution has announced a membership with the Decentralized Trials & Research Alliance (DTRA) to collaborate in the efforts to improve global adoption and education surrounding decentralized research, participant-centric trial …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), the Wixom-based developer of products for patients suffering from blood and kidney disorders, announced it would suspend develop of new pharmaceutical products, and concentrate instead …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), a pharmaceutical startup developing new drugs for endocrine diseases, announced that it had engaged SVB Leerink, a Boston-based investment bank, in a “strategic review …
DETROIT—An oral therapy that has been studied in laboratory experiments and clinical trials at the Barbara Ann Karmanos Cancer Institute, in partnership with Karyopharm Therapeutics Inc., will soon enter clinical …
ANN ARBOR –Millendo Therapeutics Inc. (Nasdaq: MLND), the Ann Arbor pharmaceutical company developing treatments for endocrine diseases, announced the grant of inducement stock options to three new employees of the …
SOUTHFIELD – A molecular biology researcher whose discoveries are on the cusp of providing new treatments for some of humanity’s most dreaded diseases provided a fascinating lecture at Lawrence Technological …
ANN ARBOR — The Ann Arbor adrenal cancer therapy developer Atterocor Inc. announced it had expanded its Phase 1 trial of ATR-101, an investigational therapy for the treatment of adrenocortical …